Drug Database
Back to search

Belgium· BE-AMP-SAM208616-00

Scheriproct 500 mg - 190 mg

A agents for treatment of hemorrhoids and anal fissures for topical use product containing cinchocaine hydrochloride, registered in Belgium by Karo Healthcare.

ATC C05A

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedScheriproct 500 mg - 190 mgATCC05AREGISTER NO.BE-AMP-SAM208616-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cinchocaine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Cinchocaine Hydrochloride
Manufacturer
Karo Healthcare
Country
Belgium (BE)
ATC code
C05A
ATC class
AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0129114

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cinchocaine hydrochloride in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cinchocaine hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Cincain, Doloposterine N Salbe
  • Finland · Orodrops
  • Greece · Otaset
  • Italy · Cincocaina Cloridrato Allergeaze Smartpractice Europe
  • Portugal · Nupercainal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f56b1107-27ce-4652-8f65-eccd5e0adf1b
GET /v1/drugs/f56b1107-27ce-4652-8f65-eccd5e0adf1b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Ointment",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Scheriproct 500 mg - 190 mg",
  "name_fr": "Scheriproct 500 mg - 190 mg",
  "name_nl": "Scheriproct 500 mg - 190 mg",
  "amp_code": "SAM208616-00",
  "strengths": [
    "500.0000",
    "500.0000",
    "190.0000",
    "190.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Cinchocaine Hydrochloride",
    "Prednisolone Caproate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use",
  "authorisation_numbers": [
    "BE208616"
  ]
}
API referenceMCP serverPlans

See everything about cinchocaine hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console